MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
Thomas F. Eleveld(Princess Máxima Center), Jan J. Molenaar(Institute of Human Genetics)
Cited by 10
Related Papers
Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma
|Cancer Research|2008|171
The cell cycle in neuroblastoma : from genomic aberrations to targeted intervention
|Data Archiving and Networked Services (DANS)|2009|0